Gym Staple’s Bizarre Cancer Twist

Person pouring probiotic pills into their hand

A supplement sitting in millions of gym bags right now may be doing something far more interesting than building muscle — and a new UCLA study has cancer researchers paying close attention.

Quick Take

UCLA researchers found creatine boosted key immune cells and slowed tumor growth in mouse melanoma models.
The same supplement has been shown to speed up cancer spread in colorectal and breast cancer mouse studies — making the picture complicated.
No human trials exist yet, and neither UCLA nor any medical body recommends creatine as a cancer treatment.
The science is early, genuinely interesting, and nowhere near your medicine cabinet yet.

What UCLA Researchers Actually Found in the Lab

A 2026 UCLA study published in the journal iScience found that creatine fuels a specific type of immune cell called a dendritic cell. These cells are the immune system’s alarm bells. They spot cancer cells, flag them, and send killer T cells to destroy them. Inside tumors, nutrients are scarce. Creatine gave those dendritic cells an energy boost that helped them do their job better. In mouse melanoma models, creatine supplementation significantly slowed tumor growth. ^[1]

The UCLA team found that dendritic cells inside tumors actually ramp up their creatine transporters — proteins that pull creatine into the cell — as if the cells are hungry for it. ^[2] When researchers blocked that transporter in mice, the immune response collapsed. Dendritic cells failed to activate. Cancer-killing T cells never got the signal. That detail matters because it suggests creatine is not just a bystander. The immune system appears to actively seek it out in the fight against tumors.

Creatine Also Helped Immunotherapy Work Better in Mice

An earlier UCLA study found that creatine made a popular class of cancer drugs work better. These drugs, called PD-1 and PD-L1 blockers, are already used in human cancer treatment. They work by taking the brakes off the immune system. When researchers added creatine to that therapy in mouse models, tumor suppression improved beyond what either approach achieved alone. ^[4] That combination angle is what has oncology researchers most interested, not creatine as a solo treatment.

The Research Has a Serious Problem That Cannot Be Ignored

A peer-reviewed study published in the journal Cell Metabolism found something that stops this story cold. In mouse models of colorectal and breast cancer, creatine did not slow tumors — it helped them spread. Creatine activated a molecular pathway called Smad2/3, which increased the cancer’s ability to invade surrounding tissue and shorten survival. ^[12] When researchers blocked the enzyme the body uses to make creatine, metastasis slowed and mice lived longer. That is the opposite of the UCLA result.

Creatine could help the immune system fight cancer more effectively, study finds | Knowridge

Creatine is best known as a popular supplement used by athletes and bodybuilders to improve strength and performance.

Now, new research from the University of California, Los Angeles… pic.twitter.com/40qLbyzet3

— Owen Gregorian (@OwenGregorian) June 22, 2026

Memorial Sloan Kettering Cancer Center, one of the most respected cancer hospitals in the world, acknowledges both findings openly. Their guidance states that creatine has suppressed tumor growth in some mouse models but promoted metastasis in colorectal and breast cancer models. ^[13] The American Society of Clinical Oncology has noted that studies in human cancer patients have so far failed to find a benefit from creatine supplementation. ^[14] That is the honest state of the science right now: real findings, real conflict, no human proof.

Why This Fits a Familiar and Frustrating Pattern

Creatine is not the first supplement to look like a cancer breakthrough in mice and stall in humans. Curcumin, quercetin, and green tea extract all showed strong anti-cancer effects in lab and animal studies. Human trials delivered little. Some supplements, like high-dose beta-carotene, actually increased cancer risk in certain groups. Over 80% of cancer survivors use dietary supplements, yet large randomized trials consistently find no preventive or treatment benefit for most of them. The gap between mouse studies and human outcomes in cancer research is wide and well-documented.

What Needs to Happen Before This Matters to You

Researchers need to test creatine in more realistic tumor models — ones that better reflect how cancer actually grows in humans. They need to figure out why creatine slows melanoma but appears to accelerate colorectal and breast cancer spread. That difference likely comes down to specific molecular pathways in different tissue types, but no one has mapped that yet. Most importantly, controlled human trials need to happen before any doctor can responsibly recommend creatine as part of cancer care. The Food and Drug Administration has not approved creatine for any cancer use, and the UCLA researchers themselves say no dietary recommendations should be drawn from their findings. ^[2]

The Honest Bottom Line on Creatine and Cancer

The UCLA research is legitimate, well-designed within its scope, and worth following. The immune cell mechanism is specific and biologically plausible. But the conflicting metastasis data from colorectal and breast cancer models is equally legitimate science, not a footnote. Anyone who tells you creatine fights cancer is running ahead of the evidence. Anyone who tells you to stop taking it because it causes cancer is doing the same. The truth is that we do not yet know enough — and in cancer research, that uncertainty deserves respect, not a sales pitch.